Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies

202138 citationslettergreen Open Access

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 32, Issue 11, pp. 1445-1447

Field-Weighted Citation Impact: 2.41